Brief: China Shineway Pharmaceutical Sees Profit Attributable For Year To Increase By Approximately 85% To 95%
03/03/2022 10:37
March 3 (Reuters) - China Shineway Pharmaceutical Group Ltd
2877.HK :
* SEES PROFIT ATTRIBUTABLE FOR YEAR TO INCREASE BY
APPROXIMATELY
85% TO 95%
* EXPECTED RESULTS DUE TO A REDUCTION IN AMORTIZATION
EXPENSE FOR
PERIOD AS A RESULT OF IMPAIRMENT CHARGE
Further company coverage: 2877.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Shineway Pharmaceutical
See all newsBrief: China Shineway Pharmaceutical Posts Q1 Turnover Of RMB624 MLN
Brief: China Shineway Pharmaceutical Declares 2026 First Interim Dividend RMB43 Cents Per Share
Brief: China Shineway Pharmaceutical Group FY Net Income RMB 840 Million
Brief: China Shineway Pharmaceutical Posts Nine Months Turnover RMB2,887 Mln
Brief: China Shineway Pharmaceutical Group Posts H1 Net Income RMB 626.5 Mln